The Princess Royal University Hospital or PRUH is a large acute district general hospital situated in Locksbottom, near Farnborough, in the London Borough of Bromley. It is managed by King's College Hospital NHS Foundation Trust.

There are 525 beds in Princess Royal University Hospital.

During the past decade, Princess Royal University Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Royal University Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "University College, London" with 2 trials sponsored, "Guy's and St Thomas' NHS Foundation Trust" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Royal University Hospital" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "King's College London" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "British Heart Foundation" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Princess Royal University Hospital" are "Breast Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Acute Kidney Injury" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Princess Royal University Hospital" in a lesser frequency.

Most popular intervention types in "Princess Royal University Hospital" are "Drug" (6 trials), "Other" (4 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Idelalisib" (2 trials), "Rituximab" (2 trials), "Accelerated RRT initiation" (1 trials), "Aromatase Inhibitors" (1 trials) and "Cardiac MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Princess Royal University Hospital" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Princess Royal University Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Princess Royal University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Royal University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".